NM_001114753.3:c.1415_1424delAGAGCTTTGT

Variant summary

Our verdict is Pathogenic.
+11 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 11 classification points (ACGS-UK Somatic Oncogenicity v2025). O1_SupportingO2_Very_StrongO3_Moderate

The NM_001114753.3(ENG):c.1415_1424delAGAGCTTTGT (p.Gln472ArgfsTer16) variant causes a frameshift change. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The gene ENG is a tumor suppressor gene (CancerMine: 3 TSG, 1 driver citations). The gene ENG is a cancer driver gene (CancerMine: 3 TSG, 1 driver citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★).

Frequency

Genomes: not found (cov: 32)

Consequence

ENG
NM_001114753.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 4.30

Publications

0 publications found
Variant links:
Genes affected
ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
ENG Gene-Disease associations (from GenCC):
  • telangiectasia, hereditary hemorrhagic, type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
  • hereditary hemorrhagic telangiectasia
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet
  • juvenile polyposis syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001114753.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 11 points.

O1Established oncogenic variant
TSG gene: ClinVar germline P/LP (single/no review) — Supporting (O1); O1 contributing sources (1.0 pts): ClinVar germline P/LP in TSG (★)
O2Null variant in tumour suppressor gene
Frameshift/stop-gained, NMD predicted, LoF oncogenic mechanism — O2 very strong (+8); Use caution in the presence of multiple transcripts; Gene confirmed as TSG in CancerMine (TSG: 3 citations, oncogene: 0 citations, driver: 1 citations).; Frameshift/stop-gained. NMD predicted: true. LoF mechanism: true. Downstream pathogenic count: 0.
O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001114753.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

ENG NM_001114753.3
MANE Select
HGVSc / HGVSpc.1415_1424delAGAGCTTTGTp.Gln472ArgfsTer16
Exon rankExon 11 of 15
frameshift
Prot: NP_001108225.1UniProt: P17813-1
ENG NM_000118.4
HGVSc / HGVSpc.1415_1424delAGAGCTTTGTp.Gln472ArgfsTer16
Exon rankExon 11 of 14
frameshift
Prot: NP_000109.1UniProt: P17813-2
ENG NM_001278138.2
HGVSc / HGVSpc.869_878delAGAGCTTTGTp.Gln290ArgfsTer16
Exon rankExon 11 of 15
frameshift
Prot: NP_001265067.1UniProt: F5GX88

Ensembl Transcripts

ENG ENST00000373203.9
TSL:1MANE Select
HGVSc / HGVSpc.1415_1424delAGAGCTTTGTp.Gln472ArgfsTer16
Exon rankExon 11 of 15
frameshift
Prot: ENSP00000362299.4UniProt: P17813-1
ENG ENST00000344849.5
TSL:1
HGVSc / HGVSpc.1415_1424delAGAGCTTTGTp.Gln472ArgfsTer16
Exon rankExon 11 of 14
frameshift
Prot: ENSP00000341917.3UniProt: P17813-2
ENG ENST00000714047.1
HGVSc / HGVSpc.1415_1424delAGAGCTTTGTp.Gln472ArgfsTer16
Exon rankExon 11 of 15
frameshift
Prot: ENSP00000519338.1UniProt: A0AAQ5BHC4

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 2 sources
GnomAD3 genomes
Cov:32
GnomAD4 genome
Cov:32
Showing 2 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Hereditary hemorrhagic telangiectasia (1)

Computational Scores

Mutation Taster
N/A0/200disease causing (ClinVar)
PhyloP100
Uncertain4.3
Showing 2 of 2 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.